RI Bio Annual Meeting

In the face of financial obstacles encountered by life sciences companies throughout 2023, the industry not only persevered but also surged forward in catalyzing advancements in gene therapies, patient-centric drug development, artificial intelligence, machine learning, and automation. As we enter 2024, the metric for gauging success among industry leaders will center on how these scientific breakthroughs can be translated into tangible and expedited benefits for patients.

Throughout the preceding year, the RI Bio team delivered comprehensive advisory services, cutting-edge education and training, dynamic forums, impactful programs, and effective advocacy efforts. These concerted endeavors were aimed at propelling the growth of RI’s life sciences ecosystem.

We’d like to invite you to join us for our RI Bio Annual Meeting, Advancing Science, Improving Lives, to review our industry and organizational progress and to learn more about what’s ahead for our RI life sciences ecosystem in 2024 and beyond.

Highlights include:

  • Progress Report on Strategic Objectives and a Look Forward – Carol Malysz, Executive Director
  • Reflections on RI Life Science Progress, Board Chair – Patrice Milos, PhD, Senior Advisor
  • Remarks on Scientific Advancements & Future Direction, Incoming Board Chair – Jaimy
    Mauricio, Senior Director, Financial Planning & Analysis, Intellia Therapeutics

Don’t miss out!

REGISTER TODAY

UPCOMING EVENTS